GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 100 filers reported holding GENERATION BIO CO in Q4 2022. The put-call ratio across all filers is 5.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,768 | -31.1% | 19,200 | 0.0% | 0.00% | – |
| Q2 2023 | $105,600 | -15.8% | 19,200 | -34.2% | 0.00% | – |
| Q1 2023 | $125,462 | -78.8% | 29,177 | -80.6% | 0.00% | – |
| Q4 2022 | $590,616 | -20.5% | 150,284 | +7.4% | 0.00% | – |
| Q3 2022 | $743,000 | -23.6% | 139,955 | -5.6% | 0.00% | -100.0% |
| Q2 2022 | $973,000 | -13.1% | 148,196 | -2.9% | 0.00% | 0.0% |
| Q1 2022 | $1,120,000 | +3.8% | 152,576 | +0.1% | 0.00% | – |
| Q4 2021 | $1,079,000 | -72.7% | 152,356 | -3.2% | 0.00% | -100.0% |
| Q3 2021 | $3,946,000 | -6.8% | 157,366 | +0.1% | 0.00% | 0.0% |
| Q2 2021 | $4,232,000 | +0.6% | 157,279 | +6.4% | 0.00% | 0.0% |
| Q1 2021 | $4,208,000 | +1550.2% | 147,874 | +1540.7% | 0.00% | – |
| Q4 2020 | $255,000 | +26.2% | 9,013 | +37.5% | 0.00% | – |
| Q3 2020 | $202,000 | – | 6,556 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
| Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
| HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
| Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
| PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
| BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
| Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
| Corton Capital Inc. | 15,493 | $102,000 | 0.10% |